ACC CardiaCast: Recent Episodes
American College of Cardiology
This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.
In this third episode of Inside the Author Studio: Behind the Scenes with the Guideline Authors, Dr. Jim Januzzi interviews guideline author Dr. Lynne Stevenson on the importance of understanding the optimal evaluation and management of patients with heart failure. Dr. Stevenson passionately explains why clinicians must understand that every patient is different and how effective therapies must be individualized and often combined to treat patients with different profiles. Listen to Dr. Stevenson elaborate on the hopes to unify heart failure across the ejection fraction and rebrand "heart failure" to "heart success" by better understanding patients to prevent progression to stage C or D.
This podcast is part of the Heart Failure & SGLT2is: The New Pillar in Care grant initiative.
Educational grant support is provided by Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly). Click here for more: https://learn.acc.org/Page/LearnSGLT2andHF
Subscribe to CardiaCast | Claim CME Credit
In this second episode of Inside the Author Studio: Behind the Scenes with the Guideline Authors, Dr. Jim Januzzi interviews guideline author Dr. Javed Butler on the efficacy of SGLT2is relative to ejection fraction and the foundational therapies for heart failure and his general strategy for prescribing therapies. Listen as Dr. Butler discusses the guideline recommendation for hospitalization initiation of guideline-directed medical therapy. In addition, Dr. Butler provides his thoughts on using artificial intelligence within the next decade to diagnose, provide treatment strategies, and predict outcomes for heart failure patients.
This podcast is part of the Heart Failure & SGLT2is: The New Pillar in Care grant initiative.
Educational grant support is provided by Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly). Click here for more: https://learn.acc.org/Page/LearnSGLT2andHF
Subscribe to CardiaCast
In this first episode of Inside the Author Studio: Behind the Scenes with the Guideline Authors, Dr. Jim Januzzi interviews guideline author Dr. Michelle Kittleson on patient-related issues and the changes in guideline classifications that will influence management. Listen to Dr. Kittleson provide some exciting developments in heart failure management regarding SGLT2is.
This podcast is part of the Heart Failure & SGLT2is: The New Pillar in Care grant initiative.
Educational grant support is provided by Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly). Click here for more: https://learn.acc.org/Page/LearnSGLT2andHF
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, and Elisabeth M. Wang PharmD, BCCP to explore best practices related to Acute myocardial infarction. In this episode, the focus includes AMI discharges.
Subscribe on iTunes | Subscribe on Google Play
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Laura Ross, PA-C, and Jonathan David MSN, RN to explore best practices related to acute myocardial infarction. In this episode, the focus includes information to consider when your patient has had an AMI.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Laura Ross PA-C, and Elisabeth M. Wang PharmD, BCCP to explore best practices related to acute myocardial infarction. In this episode, the focus includes additional AMI treatment options.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Jacqueline L Green MD, MPH, FACC and Michelle Bierig PhD, ACS to explore best practices related to Acute myocardial infarction. In this episode, the focus is AMI care in the cardiac Cath Laboratory.
Subscribe on iTunes | Subscribe on Google Play
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, and Elisabeth M. Wang PharmD, BCCP to explore best practices related to Acute myocardial infarction. In this episode, the focus includes a deep dive in acute medications for AMIs.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Laura Ross PA-C, and Elisabeth M. Wang PharmD, BCCP to explore best practices related to Acute myocardial infarction. In this episode, the focus includes additional AMI treatment options.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Jacqueline L Green MD, MPH, FACC to explore best practices related to acute myocardial infarction. In this episode, the focus is on an introduction to AMI.
Subscribe on iTunes | Subscribe on Google Play |
Join Akl Fahed, MD, MHP, FACC and Dianna Milewicz, MD, PhD as they discuss using genetic testing to inform treatment planning and care management of patients with aortopathies.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, RCIS, CPHQ, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Benjamin Hocutt MSN, ACNP, AACC, Robert Page PharmD, and Lauren Eyadiel PA-C to explore best practices related to heart failure. In this episode, the focus is on advanced heart failure.
Join Akl Fahed MD, MHP, FACC and Pradeep Natarajan MD, FACC as they discuss using genetic testing to inform treatment planning and care management of patients with lipids disorders.
Subscribe on iTunes | Subscribe on Google Play
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, RCIS, CPHQ, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Robert Page PharmD, and Lauren Eyadiel PA-C to explore best practices related to heart failure. In this episode, the focus is on how team-based care is used in heart failure management.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, RCIS, CPHQ, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, and Benjamin Hocutt MSN, ACNP, AACC to explore best practices related to heart failure. In this episode, the focus is on invasive treatment options for heart failure.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, RCIS, CPHQ, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, Benjamin Hocutt MSN, ACNP, AACC, and Robert Page PharmD to explore best practices related to heart failure. In this episode, the focus is on additional heart failure medical therapies.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, RCIS, CPHQ, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN, and Robert Page PharmD to explore best practices related to heart failure. In this episode, the focus is on the four pharmacological pillars of heart failure.
Subscribe on iTunes | Subscribe on Google Play |
Join Akl Fahed MD, MHP, FACC and Carolyn Ho MD as they discuss using genetic testing to inform treatment planning and care management of patients with cardiomyopathies and arrhythmias.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Ben Hocutt MSN, AG-ACNP to explore best practices related to heart failure. In this episode, the focus is on an introduction to heart failure.
In this episode Richard Cheng MD and Michelle Kittleson MD discuss treatment for amyloidosis, including evidence-based therapies, pitfalls, and advanced heart failure management.
This podcast is part of the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment grant initiative. (https://learn.acc.org/Page/LEARNCARDIACAMYLOID)
Educational grant support is provided by Alnylam.
Subscribe on iTunes | Subscribe on Google Play |
In this episode, Jan Griffin MD and Michelle Kittleson MD discuss diagnosis of amyloidosis, including the recommended algorithm and pitfalls. What questions do you typically ask when looking for ‘red flags’ for cardiac amyloidosis in a patient you are seeing for the first time in clinic, and what do you tend to look for on exam, labs, ECG and echo that would make you suspect amyloidosis as the cause of heart failure?
This podcast is part of the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment grant initiative.
https://learn.acc.org/Page/LEARNCARDIACAMYLOID
Educational grant support is provided by Alnylam.
Subscribe on iTunes | Subscribe on Google Play |
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Ayesha Ather, PharmD, BCPS, BCCP to explore best practices related to atrial fibrillation. In this episode, the focus is on anticoagulation pharmacological options for people with AFib.
In this episode, Amrut Ambardekar MD and Michelle Kittleson MD discuss red flags and clinical clues when diagnosing cardiac amyloidosis. Why is it important to diagnose cardiac amyloidosis, and what are some of the symptoms and signs? What are some red-flags that should make you think about cardiac amyloidosis?
This podcast is part of the Cardiac Amyloidosis: Accelerating Diagnosis and Treatment grant initiative.
Educational grant support is provided by Alnylam. Click here for more: https://learn.acc.org/Page/LEARNCARDIACAMYLOID
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Ayesha Ather, PharmD, BCPS, BCCP to explore best practices related to atrial fibrillation. In this episode, the focus is on rhythm control pharmacological treatment options for people with AFib.
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Ayesha Ather, PharmD, BCPS, BCCP to explore best practices related to atrial fibrillation. In this episode, the focus is on pharmacological treatment options for people with AFib.
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Joe Giron, RN, CRT(R)(F), RCIS, RCES, CEPS to explore best practices related to atrial fibrillation. In this episode, the focus is on treatment options for people with AFib.
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Mary Huntsinger, NP, AACC to explore best practices related to atrial fibrillation. In this episode, the focus is on atrial fibrillation in the inpatient setting.
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. In this first set of panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Mary Huntsinger, NP, AACC to explore best practices related to atrial fibrillation. In this epsode, the focus is on atrial fibrillation in the outpatient setting.
“PulseCheck” is a new series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical information surrounding the challenges that nurses and allied health professionals face every day. In this first set of panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Adam Burget RN and Mary Huntsinger NP, AACC to explore best practices related to atrial fibrillation, including an introduction and overview to the disease.
In this podcast, alternative models of cardiac rehabilitation (CR) are discussed by Drs. Brown and Tracy, with Dr. Forman serving as moderator. The rationale for the needs for remote and hybrid models of care are presented, as well as the definitions of what these alternative models should be (incorporating all of the key components of the standard of care facility based CR). Specific formats (synchronous and asynchronous) are also explored. Broad conceptual value to patients is described as well as specific experiences at Rush University, where remote and hybrid options are available, as well as site-based cardiac rehabilitation care. The safety and reimbursement is also be reviewed.
In this episode, Drs. Matt Martinez and Theodore Abraham discuss “What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten” for the treatment of hypertrophic cardiomyopathy, and its mechanisms of action.
Are you trying to decide if the Collaborative Maintenance Pathway (CMP) is for you? When it comes to meeting maintenance of certification (MOC) requirements, you have choices! Thousands of your peers have chosen to participate in the CMP. Listen to this interview detailing participants personal experiences and insights.
In this episode, Drs. Matt Martinez and Ahmad Masri discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and mechanisms of action.
In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Dr. Tammy Brady discusses the numerous, often ignored, factors that can lead to inaccurate blood pressure assessment and the degree to which this may affect clinical management. Topics will include cuff size (with a particular focus on Dr. Brady’s recent research), insufficient rest before measuring BP, prescription medications, talking, and presence of staff, among others.
In this episode, developed by the ACC Prevention of Cardiovascular Disease Section’s Hypertension Work Group, Drs. Beth Abramson, Cesar Andres, Nadia Khan, and Karen Tran provide an international perspective on guidelines, care gaps, and ways to close these care gaps.
In this episode, Drs. Matt Martinez and Sara Saberi discuss the recent approval by the FDA of the cardiac myosin inhibitor Mavacamten for the treatment of hypertrophic cardiomyopathy, and what sorts of patients are best suited for this treatment.
In this episode, Dr. Michael Shapiro and Dr. Salim Virani discuss the current treatment options for FH, including statin therapy, lifestyle modifications, and non-statin therapy.
In this episode, Dr. Michael Shapiro and Dr. Pam Taub discuss the clinical presentation, natural history, and diagnosis of familial hypercholesterolemia.
In this episode, Dr. Michael Shapiro and Dr. Christie Ballantyne discuss the epidemiology, genetics, and pathophysiology of HeFH and HoFH.
Educational grant support provided by: Regeneron
To visit the course page for the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment project, click here!
Subscribe on iTunes | Subscribe on Google Play
In this episode, Drs. Leslie Davis and Dr. Ciantel (Adair) Blyler discuss the importance of appropriate assessment of blood pressure in the office setting. They will review appropriate technique, as well as common pitfalls that can result in inaccurate or misleading measurements. Given the importance of accurate blood pressure assessment in clinical decision making, this podcast will assist all providers in ensuring the provision of high-quality care.
In this episode, Dr. Brian Olshansky and Dr. Dan Sorajja discuss identifying the next steps for treatment after syncope assessment, including pacemakers, ablation, and drug therapy.
In this episode, Drs. George Stergiou and Florian Rader discuss the use of home blood pressure monitoring in the diagnosis, management, and treatment of hypertension. This panel will specifically focus on the differences between home and ambulatory blood pressure monitoring, the clinical situations in which these should be utilized, and the interpretation of this data by clinicians. Further, these experts will review how to discuss home blood pressure monitoring with patients and how to address common questions that arise.
In this episode, Dr. Brian Olshansky and Dr. Roopinder Sandhu discuss the initial assessment of patients with syncope, considering: the importance of medical history, distinguishing cardiac and non-cardiac causes of syncope, and risk stratification.
In this episode, Dr. Brian Olshansky and Dr. Satish Raj discuss autonomic function testing in patients with syncope and suspected postural orthostatic tachycardia syndrome (POTS).
In this episode, Dr. Deepak Bhatt and Dr. George Bakris discuss the diagnosis of resistant hypertension, strategies to manage patient lifestyle, and the use of combination therapy.
Educational grant support provided by Medtronic. To visit the hub for the Overcoming Challenges in Hypertension Management grant, click here.
Subscribe on iTunes | Subscribe on Google Play |
In this episode, Dr. Suzanne Oparil and Dr. Sandra Taler discuss strategies to address deteriorating control rates of hypertension, including leveraging combinations of antihypertensive drugs, improving patient adherence, and increasing clinician inertia.
Educational grant support provided by Medtronic. To visit the hub for the Overcoming Challenges in Hypertension Management grant, click here.
Subscribe on iTunes | Subscribe on Google Play |
In this episode, Keith Ferdinand, MD and Chloe Villavaso, APRN discuss strategies to improve adherence in hypertensive patients, including communication tactics, shared decision making, and monitoring blood pressure outside of the office.
Educational grant support provided by Medtronic. To visit the hub for the Overcoming Challenges in Hypertension Management grant, click here.
Subscribe on iTunes | Subscribe on Google Play |
Much of our dietary evidence comes from non-randomized epidemiologic data. In this episode, Robert Ostfeld, MD, MSc, FACC, and Walter Willett, MD, DrPH, discuss why findings from prospective, epidemiologic cohort studies are important in informing dietary recommendations, and what dietary principles are healthful across multiple populations, including the following key takeaways:
- Personal and planetary health are equally important for our own well-being and for that of future generations; a healthy, predominantly plant-based diet can achieve both of these goals.
- Although sustainable diets are necessary for planetary health, they are not sufficient; improvements in agricultural production, reduction in food waste, and rapid conversion to green energy are all needed.
For more, visit www.acc.org/CardioNutrition
Subscribe to CardiaCast
It’s a wrap! In this episode of CardioNutrition, Robert Ostfeld, MD, MSc, FACC, recaps the journey through the CardioNutrition program from macronutrient nuts and bolts, to specific dietary patterns, and through application to daily practice.
For more, visit www.acc.org/CardioNutrition
Subscribe to CardiaCast
In this episode of CardioNutrition, Robert Ostfeld, MD, MSc, FACC, discusses a clinical case from Montefiore’s Cardiac Wellness Program highlighting the potential impact of dietary change on systolic dysfunction, noting that a plant-based dietary pattern was temporally associated with normalization of left ventricular ejection fraction in a patient with heart failure and reduced ejection fraction.
For more, visit www.acc.org/CardioNutrition
Subscribe to CardiaCast
How do you incorporate nutrition counseling into your already busy clinical life? What are some specific, time-effective suggestions that busy clinicians can use? In this episode, Robert Ostfeld, MD, MSc, FACC, and Eugenia Gianos, MD, FACC, discuss ways to incorporate nutrition counseling into busy clinical practice, including the following key takeaways:
- Nutrition counseling is at the core of doctoring, and a healthful diet is recommended by the ACC’s prevention guidelines.
- Incorporating educational hand-outs, short educational videos, and screening questionnaires into practice is feasible.
- Incorporating nutrition counseling into your practice may improve patient outcomes and make practicing more rewarding.
For more, visit www.acc.org/CardioNutrition.
We must keep the lights on, so how do we get reimbursed for nutrition counseling? In this episode, Robert Ostfeld, MD, MSc, FACC; Penny Kris-Etherton, PhD, RD; and Geeta Sikand, MA, RDN, CDE, CLS, discuss CardioNutrition on the front lines, including the following key takeaways:
- Registered dieticians (RDs) can bill for medical nutrition therapy for a number of conditions when patients are referred to RDs by a physician.
- The number of conditions RDs can bill for medical nutrition therapy would expand if the Medical Nutrition Therapy Act is passed into law.
- Physicians can incorporate their time spent counseling patients on nutrition into time-based billing.
- RDs and physicians working together can help optimize patient outcomes.
For more, visit www.acc.org/CardioNutrition.
Subscribe to CardiaCast
In this episode, Robert Ostfeld, MD, MSc, FACC, discusses a case from the Cardiac Wellness Program at Montefiore where dietary change was associated with improved angina, including the following key takeaways:
- Healthful dietary patterns share common traits: reducing highly processed foods and increasing fruits and vegetables.
- Even small healthful dietary changes are associated with improved health outcomes.
- In this case, a gentleman’s progressive angina gradually resolved when he began consuming a minimally processed plant-based diet.
For more, visit www.acc.org/CardioNutrition.
Subscribe to CardiaCast
Intermittent fasting has become very popular, but what are the data to support that it is effective and/or safe? In this episode, Robert Ostfeld, MD, MSc, FACC, and Ethan Weiss, MD, discuss an intermittent fasting dietary pattern, including the following key takeaways:
- Although animal studies show promise, we await additional human data prior to potentially recommending this eating pattern.
- In a randomized controlled human trial, time-restricted eating did not lead to greater weight loss than did eating without time restriction.
For more, visit www.acc.org/CardioNutrition.
Subscribe to CardiaCast
What is a plant-based diet? How do you recommend counseling patents to adopt more of a plant-based diet? In this episode, Robert Ostfeld, MD, MSc, FACC, and Danielle Belardo, MD, discuss a plant-based dietary pattern. For more, visit www.acc.org/CardioNutrition.
What is a ketogenic diet? Is a low-carb diet healthful? In this episode, Robert Ostfeld, MD, MSc, FACC, and Kevin Hall, PhD, and discuss a ketogenic dietary pattern. For more, visit www.acc.org/CardioNutrition.
The recent prevention guidelines from the American College of Cardiology recommend for all adults a healthy diet that emphasizes consuming vegetables, fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the intake of trans fats, processed meats, refined carbohydrates, and sweetened beverages. In this episode, Robert Ostfeld, MD, MSc, FACC, and Erin Michos, MD, MHS, FACC, discuss a Mediterranean dietary pattern. For more, visit www.acc.org/CardioNutrition.
Nutrition is the most effective tool in the cardiovascular clinician's arsenal! In this episode, Robert Ostfeld, MD, MSc, FACC, and Andrew Freeman, MD, FACC, discuss our protein needs, protein sources and their healthfulness, and how plant-based foods can be excellent protein sources. For more, visit www.acc.org/CardioNutrition.
Substantial confusion exists about types and amounts of fat in the diet and their impact on cardiovascular risk. Understanding fats and their food sources, along with some of the inherent challenges in studying nutrition, may help practitioners and consumers wade through the confusion. In this CardioNutrition episode, Robert Ostfeld, MD, MSc, FACC, and Kevin Klatt, PhD, RD, discuss the skinny on fats and omega 3s. For more, visit www.acc.org/CardioNutrition.
In this CardioNutrition episode, Robert Ostfeld, MD, MSc, FACC, and Kim Allan Williams, Sr., MD, MACC, discuss what the ACC dietary guidelines say. For more, visit www.acc.org/CardioNutrition.
What is the difference between a whole and refined carb? Are carbs healthy or unhealthy? In this CardioNutrition episode, Robert Ostfeld, MD, MSc, FACC, and Walter Willett, MD, PhD, discuss carbs, fiber, and grains—oh my! For more, visit www.acc.org/CardioNutrition.
In this CardioNutrition episode, host Robert Ostfeld, MD, MSc, FACC, Director of Preventive Cardiology at Montefiore Health System, and Professor of Medicine at the Albert Einstein College of Medicine, introduces the CardioNutrition program. For more, visit www.acc.org/CardioNutrition.
In this episode, Alanna Morris, MD, MSc, FACC; Javed Butler, MBBS, FACC; John McMurray, MD, FACC; and Muthiah Vaduganathan, MD, FACC, discuss the role of sodium-glucose transport protein 2 inhibitors in the new hope in heart failure (HF). Visit the Clinical Spotlight Series: Shining a Light on New HF Pharmacotherapies online course page for more information and resources. Educational Support provided by AstraZeneca, Cytokinetics, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.
In this episode, Kim Eagle, MD, MACC, asks Matthew Martinez, MD, FACC, and Steve Ommen, MD, FACC, all of the questions you wish you could ask about hypertrophic cardiomyopathy and the new ACC guidelines.
In this episode, Frederick Ruberg, MD, and Mathew Maurer, MD, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on noninvasive means, disease course and management of heart failure and conduction disease, as well as the recently approved therapeutics for the two major types of cardiac amyloidosis: light-chain and transthyretin. (Educational grant support is provided by Janssen Oncology.)
In this episode, JoAnn Lindenfeld, MD, FACC; Vinay Badhwar, MD, FACC; Sammy Elmariah, MD, MPH, FACC; and Rebecca T. Hahn, MD, FACC, discuss the 2020 Expert Consensus Decision Pathway for mitral regurgitation.
In this episode, Michael Mack, MD, MACC, Kim Eagle, MD, MACC, and Rebecca Hahn, MD, FACC, discuss important changes in the 2020 valvular guideline update.
In this episode, Paul Grayburn, MD, FACC, and Rebecca Hahn, MD, FACC, discuss the five key elements of a comprehensive mitral regurgitation echocardiogram: etiology/morphology, severity, left ventricular size and function, left atrial size and pulmonary artery pressure estimate, and anatomic suitability for intervention.
In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny are joined by William Schaffner to discuss the importance of influenza vaccination particularly this year in the midst of the coronavirus disease 2019 pandemic.
In this episode, Scott Solomon, Ankeet Bhatt, Orly Vardeny, Mohammad Madjid, and Jay Udell take a step back to dive deeper into the mechanisms behind the association between influenza and acute cardiovascular events. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.
In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny discuss the intersection of influenza and cardiology and why cardiovascular practitioners should be concerned about influenza, particularly in the era of coronavirus disease 2019. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.
In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the main features from the recently published 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and how to apply the key points from this document in your practice.
Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.
In this episode, Christopher Granger is joined by Melissa Magwire, a registered nurse and Practice Manager at Saint Luke's Cardiometabolic Center Alliance, to discuss advances in how to optimally treat patients with diabetes and cardiovascular disease and how to spread the model for organizing this care across the United States.
In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the role of GLP-1 receptor agonists and SGLT2 inhibitors in cardiology, what cardiologists need to know to use these drugs safely and effectively, and how important it is to understand their role in the use of these drugs
In this episode, Christopher Granger and Robert Eckel discuss how to improve the care of patients with type 2 diabetes and cardiovascular disease, including using antihyperglycemic drugs that have relatively recently been shown to have an important effect on reducing cardiovascular outcomes. Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.
In this episode, Michelle Kittleson discusses five high-yield tips for the diagnosis and management of hypertrophic cardiomyopathy.
Hear about tomorrow's emerging sources of real-world data and how the role of the clinician at the bedside contributes to this burgeoning field. Dr. Ty Gluckman, Dr. Nihar Desai, and Dr. Rashmee Shah discuss how researchers and clinicians can shape their career trajectories to take part in this data revolution, both utilizing and contributing to real-world evidence that supports quality metrics, institutional improvements, and better patient care.
As patient populations increase in complexity, the use of real-world evidence (RWE) to identify sub-populations that need non-traditional approaches to solving clinical problems is likely to increase as well. Dr. Ty Gluckman and Dr. Nihar Desai explain how RWE can bridge the gaps in randomized controlled trial evidence, supporting clinical decision-making with evidence that better reflects your real-world patient population.
Every day, a wealth of clinical information is generated, creating a treasure trove of data with extraordinary implications for patient care. Amid today's data revolution, cardiovascular clinicians can leverage data from electronic health records (EHRs) and registries, claims databases, and at-home monitoring devices to improve the delivery of quality patient care. Dr. Ty Gluckman and Dr. Rashmee Shah explain how to leverage structured and unstructured data from EHRs and what the future of using these curated data sets for research looks like.
In this podcast, Heather Gornik discusses essentials of the ankle-brachial index. Assessment and diagnosis are examined in depth. This is a rebroadcast of the clinical focus session at ACC.19.
In this fourth and final episode of the four-part series, Haider Warraich focuses on palliative care for patients with heart failure who have left ventricular assist devices, highlighting important conversations to have with patients and their families and caregivers.
In this third episode of the four-part series, Haider Warraich explores a unique subset of patients with heart failure who benefit from the implantation of left ventricular assist devices in combination with palliative care.
In this second episode of the four-part series, Haider Warraich discusses integrating heart failure (HF) care with palliative care, answers questions submitted via social media, and offers tips on how to navigate the conversation about palliative care with patients with HF.
In this first episode of the four-part series, Haider Warraich defines the clinical diagnosis of heart failure, including its causes, symptoms, and management, and palliative care, which he differentiates from hospice care.
In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.
In this podcast, Naomi Hamburg discusses risk assessment and peripheral arterial disease (PAD) therapies in patients. Identification of PAD, exercise interventions, and pharmacotherapy are examined. This is a rebroadcast from the clinical focus session at ACC.19.
In this podcast, Kimberly Guibone and Zachary Goldberger discuss the future of syncope care. The current state of care, syncope centers, and accurate diagnosis of patients are examined. This is a rebroadcast from the clinical focus session at ACC.19.
This podcast discusses the article "Lower Cardiovascular Risk Associated with SGLT-2i in >400,000 Patients: The CVD-REAL 2 Study." The multinational study explores real world evidence on the use of sodium-glucose cotransporter-2. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
This podcast discusses the risks and benefits of starting new diabetes therapies on a patient with type 2 diabetes. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
This podcast discusses monitoring patients who have been started on a new diabetes therapy, such as sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide 1 receptor agonists. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients.
This podcast discusses the article "Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis." As the incidence of type 2 diabetes mellitus rises in the United States, understanding the cardioprotective effects of new drug classes will prepare you to better treat your patients. Learn how the classification of diabetes mellitus has changed from describing a homogenous group to a heterogeneous group and how that affects treatment.
This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial will help prepare you to better treat your patients.
This podcast discusses controversies in lipid management, including the safety of very low low-density lipoprotein cholesterol levels, the role of PCSK9 in high-risk patients for primary prevention, and the use of formal risk assessment and imaging in primary prevention.
This podcast discusses new data pertaining to glucagon-like peptide-1 receptor agonists in the treatment of diabetes and their cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the ELIXA trial (Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 [Lixisenatide]) will prepare you to better treat your patients.
This podcast discusses the importance of the patient to the care team, particularly regarding medication adherence, and considers the roles of the pharmacists, nurse practitioners, and physician assistants as well as the physician.
This podcast discusses the top 10 things you should remember from the ACC Focused Update on Non-Statin Therapies For LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: Expert Consensus Decision Pathway.